Nalaganje...

Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas

Previous studies suggest that hyperprolactinaemia might have adverse effects on lipid and glucose metabolism. We therefore aimed to evaluate whether dopamine agonist treatment with cabergoline has significant effects on blood lipids, fasting glucose and HbA1c levels in patients with micro- or macrop...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Metab Brain Dis
Main Authors: Schwetz, Verena, Librizzi, Rosaria, Trummer, Christian, Theiler, Georg, Stiegler, Claudia, Pieber, Thomas R., Obermayer-Pietsch, Barbara, Pilz, Stefan
Format: Artigo
Jezik:Inglês
Izdano: Springer US 2016
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5566581/
https://ncbi.nlm.nih.gov/pubmed/27525431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11011-016-9882-2
Oznake: Označite
Brez oznak, prvi označite!